serw-MX  [xml]  
 


    
 DeCS Categories

D04 Polycyclic Compounds .
D04.210 Fused-Ring Compounds .
D04.210.500 Steroids .
D04.210.500.668 Norsteroids .
D04.210.500.668.651 Norpregnanes .
D04.210.500.668.651.443 Norpregnadienes .
D04.210.500.668.651.443.680 Promegestone .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.826 Receptors, Cytoplasmic and Nuclear .
D12.776.826.750 Receptors, Steroid .
D12.776.826.750.350 Receptors, Estrogen .
D12.776.930 Transcription Factors .
D12.776.930.778 Receptors, Steroid .
D12.776.930.778.350 Receptors, Estrogen .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.399 Hormones, Hormone Substitutes, and Hormone Antagonists .
D27.505.696.399.472 Hormones .
D27.505.696.399.472.161 Androgens .
D27.505.696.399.472.858 Progestins .
D27.505.696.875 Reproductive Control Agents .
D27.505.696.875.360 Contraceptive Agents .
D27.505.696.875.360.276 Contraceptive Agents, Female .
D27.505.696.875.360.276.210 Contraceptives, Oral .
D27.505.696.875.360.276.210.277 Contraceptives, Oral, Hormonal .
D27.505.696.875.360.276.310 Contraceptives, Postcoital .
D27.505.954 Therapeutic Uses .
D27.505.954.705 Reproductive Control Agents .
D27.505.954.705.360 Contraceptive Agents .
D27.505.954.705.360.276 Contraceptive Agents, Female .
D27.505.954.705.360.276.210 Contraceptives, Oral .
D27.505.954.705.360.276.210.277 Contraceptives, Oral, Hormonal .
D27.505.954.705.360.276.310 Contraceptives, Postcoital .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Contraceptives, Postcoital .
Contraceptive Agents, Post-Coital .
Contraceptive Agents, Postcoital .
Contraceptives, Post-Coital .
Emergency Contraceptives .
Contraceptive Agents, Post Coital .
Contraceptives, Emergency .
Contraceptives, Post Coital .
Morning After Pill .
Post-Coital Contraceptive Agents .
Post-Coital Contraceptives .
Postcoital Contraceptive Agents .
Morning-After Pill .
Postcoital Contraceptives .
Contraceptive substances to be used after COITUS. These agents include high doses of estrogenic drugs; progesterone-receptor blockers; ANTIMETABOLITES; ALKALOIDS, and PROSTAGLANDINS. .
1.00
761835
 
Contraceptives, Oral, Hormonal .
Contraceptive Agents, Estrogen .
Contraceptive Agents, Oral, Hormonal .
Hormonal Oral Contraceptive Agents .
Oral Contraceptive Agents, Hormonal .
Oral Contraceptives, Hormonal .
Agents, Estrogen Contraceptive .
Contraceptives, Hormonal Oral .
Estrogen Contraceptive Agents .
Hormonal Oral Contraceptives .
Oral contraceptives which owe their effectiveness to hormonal preparations. .
0.32
1755016
 
Promegestone .
R-5020 .
R5020 .
RU-5020 .
RU5020 .
Surgestone .
R 5020 .
RU 5020 .
17,21-Dimethyl-19-nor-4,9-pregnadiene-3,20-dione .
Promestone .
A synthetic progestin which is useful for the study of progestin distribution and progestin tissue receptors, as it is not bound by transcortin and binds to progesterone receptors with a higher association constant than progesterone. .
0.31
 
Progestins .
Gestagen .
Gestagen Effect .
Gestagen Effects .
Gestagenic Agents .
Gestagenic Effect .
Gestagenic Effects .
Gestagens .
Progestagenic Agents .
Progestagens .
Progestational Agents .
Progestational Compounds .
Progestational Hormones .
Progestin .
Progestin Effect .
Progestin Effects .
Progestogen Effect .
Progestogen Effects .
Effect, Gestagen .
Effect, Gestagenic .
Effect, Progestin .
Effect, Progestogen .
Effects, Gestagen .
Effects, Gestagenic .
Effects, Progestin .
Effects, Progestogen .
Progestogens .
Progestational Hormones .
Progestational Hormone Analogs .
Progestin Analogs .
Progestational Hormones, Synthetic .
Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. .
0.31
1378670
 
Androgens .
Androgen Effect .
Androgen Effects .
Androgen Receptor Agonists .
Androgenic Agents .
Androgenic Compounds .
Agents, Androgenic .
Agonists, Androgen Receptor .
Compounds, Androgenic .
Effect, Androgen .
Effects, Androgen .
Receptor Agonists, Androgen .
Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. .
0.31
29822358
 
Receptors, Estrogen .
Estrogen Nuclear Receptor .
Estrogen Receptor Type I .
Estrogen Receptor Type II .
Estrogen Receptors Type I .
Estrogen Receptors Type II .
Receptor, Estrogen Nuclear .
Receptors, Estrogen, Type I .
Receptors, Estrogen, Type II .
Nuclear Receptor, Estrogen .
Estrogen Receptors .
Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. .
0.30
22234801